At-home blood collection and micro sampling devices market is projected to grow at a CAGR of 10.7 %.
Roots
Analysis has done a detailed study on At-Home Blood Collection and Micro Sampling
Devices market, 2021-2030, covering key aspects of the industry’s evolution
and identifying potential future growth opportunities.
To order this 190 page report, which features
95+ figures and 110+ tables, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html
Key Market Insights
§
The ongoing COVID-19 pandemic has accelerated the pace at
which the healthcare sector is evolving, thereby, spurring innovations that
allow patients to collect blood samples at-home as well as monitor their health
remotely
§
Presently, close to 50 at-home blood collection and micro
sampling devices are available / being developed; majority of the firms engaged
in this domain are start ups or small companies located in the US
§
Most of the at-home devices
intended for collection of whole capillary blood are presently marketed; DBS
technology, used for preparation of dried blood spot cards, has emerged as the
most popular platform
§
In pursuit of gaining a competitive edge, stakeholders are
actively expanding their product portfolios and upgrading their devices, via
incorporation of advanced features
§
Over the years, the intellectual
property related to blood collection devices has grown at a commendable pace,
with majority of the patents being filed by industry players
§
The growing interest of the
stakeholders is also reflected from the recent rise in partnership activity; a
significant proportion of the deals inked till date were focused on market
expansion
§
To support the ongoing innovation
in this domain, private and public investors have made substantial capital
investments, worth ~USD 650 million, in initiatives of various industry
stakeholders
§
Given the favourable increase in
adoption of at-home
blood collection and micro sampling devices during the COVID-19 pandemic,
the market is anticipated to witness significant growth in the foreseen future
For
more information, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter
Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of
At-Home Blood Collection and Micro Sampling Devices
3.3. Applications
of Blood Sampling and Testing
3.3.1. Complete
Blood Count
3.3.2. Basic Metabolic
Panel
3.3.3. Lipoprotein
Panel
3.4. Types of
Blood Sampling
3.4.1. Dried Blood
Sampling
3.4.2. Wet Blood
Sampling
3.5. Benefits of
At-Home Blood Collection
3.6. Methods Used
for At-Home Blood Collection
3.6.1. Fingerstick
Method
3.6.2. Press Button
Method
3.6.3. Heel-stick
Method
3.7. Types of
At-Home Blood Collection and Micro Sampling Devices
3.7.1. Dried Blood
Spot Collection Kits
3.7.2. Microtainer
Tubes
3.8. Future
Perspectives
4. MARKET
OVERVIEW
4. Market Overview
4.1. Chapter Overview
4.2. At-Home Blood Collection and Micro Sampling
Devices: Overall Market Landscape
4.2.1. Analysis by
Device Class
4.2.2. Analysis by
Current Status of Development
4.2.3. Analysis by
Regulatory Approvals / Certifications Received
4.2.4. Analysis by
Type of Technology
4.2.5. Analysis by
Device Usage
4.2.6 Analysis by
Type of Sample
4.2.7. Analysis by
Blood Sample State
4.2.8. Analysis by
Volume of Sample Collected
4.2.9. Analysis by
Puncture Site
4.2.10. Analysis by
Method of Sample Collection
4.2.11. Analysis by
Storage Temperature
4.2.12. Analysis by
Application Area
4.3. At-Home
Blood Collection and Micro Sampling Devices: List of Developers
4.3.1. Analysis by
Year of Establishment
4.3.2. Analysis by
Company Size
4.3.3. Analysis by
Geography
4.3.4. Analysis by
Year of Establishment, Company Size and Location of Headquarters
4.4. Most Active
Players: Analysis by Number of Products
5. PRODUCT
COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions
and Key Input Parameters
5.3. Methodology
5.3.1. Product
Competitiveness Analysis: North America
5.3.2. Product
Competitiveness Analysis: Europe
5.3.3. Product
Competitiveness Analysis: Asia-Pacific
6. COMPANY
PROFILES
6.1. Chapter Overview
6.2. EUROIMMUN
6.2.1. Company Overview
6.2.2. Product
Portfolio
6.2.3. Recent
Developments and Future Outlook
6.3. Everlywell
6.3.1. Company
Overview
6.3.2. Product
Portfolio
6.3.3. Recent
Developments and Future Outlook
6.4. Labcorp
6.4.1. Company
Overview
6.4.2. Product
Portfolio
6.4.3. Recent
Developments and Future Outlook
6.5. Labonovum
6.5.1. Company
Overview
6.5.2. Product
Portfolio
6.5.3. Recent
Developments and Future Outlook
6.6. Lameditech
6.6.1. Company
Overview
6.6.2. Product
Portfolio
6.6.3. Recent Developments
and Future Outlook
6.7. Quest
Diagnostics
6.7.1. Company
Overview
6.7.2. Product
Portfolio
6.7.3. Recent
Developments and Future Outlook
6.8. Spot On
Sciences
6.8.1. Company
Overview
6.8.2. Product
Portfolio
6.8.3. Recent
Developments and Future Outlook
6.9. Tasso
6.9.1. Company
Overview
6.9.2. Product
Portfolio
6.9.3. Recent
Developments and Future Outlook
6.10. Weavr Health
6.10.1. Company
Overview
6.10.2. Product
Portfolio
6.10.3. Recent
Developments and Future Outlook
6.11. YourBio Health
6.11.1. Company
Overview
6.11.2. Product
Portfolio
6.11.3. Recent
Developments and Future Outlook
7. PATENT
ANALYSIS
7.1. Chapter Overview
7.2. At-Home
Blood Collection and Micro Sampling Devices: Patent Analysis
7.2.1. Scope and Methodology
7.2.2. Analysis by
Publication Year
7.2.3. Analysis by
Publication Year and Type of Patent
7.2.4. Analysis by
Geography
7.2.5. Analysis by
CPC Symbols
7.2.6. Analysis by
Emerging Focus Area
7.2.7. Most Active
Players: Analysis by Number of Patents
7.2.8. Patent
Benchmarking Analysis
7.2.9. Patent
Valuation Analysis
7.2.10. Overall
Intellectual Property Portfolio: Analysis by Type of Organization
8. PARTNERSHIPS
8.1. Chapter Overview
8.2. Partnership
Models
8.3. At-Home
Blood Collection and Micro Sampling Devices: List of Partnerships
8.3.1. Analysis by
Year of Partnership
8.3.2. Analysis by
Type of Partnership
8.3.3. Analysis by
Year and Type of Partnership
8.3.4. Analysis by
Focus Area
8.3.5. Analysis by
Year of Partnership and Focus Area
8.3.6. Analysis by
Type of Partnership and Focus Area
8.3.7. Analysis by
Therapeutic Area
8.3.8. Analysis by
Region
8.3.8.1. Continent-wise
Distribution
8.3.8.2. Intercontinental
and Intracontinental Distribution
8.3.8.3. Country-wise
Distribution
8.3.9. Most Active
Players: Analysis by Number of Partnerships
9. FUNDING
AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of
Funding
9.3. At-Home
Blood Collection and Micro Sampling Devices: Funding and Investment Analysis
9.3.1. Analysis of
Number of Funding Instances by Year
9.3.2. Analysis by
Amount Invested
9.3.3. Analysis by
Type of Funding
9.3.4. Analysis by
Year and Type of Funding
9.3.5. Analysis of
Amount Invested by Geography
9.3.6. Most Active
Players: Analysis by Number of Funding Instances and Amount Invested
9.3.7. Key
Investors: Analysis by Number of Funding Instances
9.3.8. Analysis by
Purpose of Investment
9.3.9. Analysis by
Application Area
10. COST
SAVING ANALYSIS
10.1. Chapter Overview
10.2. Key
Assumptions and Methodology
10.3. Overall Cost
Saving Potential of At-Home Blood Collection and Micro Sampling Devices
10.3.1. North America
Scenario
10.3.2. Europe
Scenario
10.3.3. Asia-Pacific
Scenario
11. MARKET
FORECAST
11.1. Chapter Overview
11.2. Forecast Methodology
and Assumptions
11.3. Global
At-Home Blood Collection and Micro
Sampling Devices Market, 2021-2030
11.3.1. At-Home Blood
Collection and Micro Sampling Devices Market, 2021-2030: Analysis by Blood Sample
State
11.3.1.1. At-Home Blood Collection and Micro Sampling
Devices Market for Dried Blood Samples, 2021- 2030
11.3.1.2. At-Home Blood Collection and Micro Sampling
Devices Market for Liquid Blood Samples, 2021-2030
11.3.2. At-Home Blood
Collection and Micro Sampling Devices Market, 2021-2030: Analysis by Method of
Sample Collection
11.3.2.1. At-Home Blood Collection and Micro Sampling
Devices Market for Fingerstick Method of Sample Collection, 2021-2030
11.3.2.2. At-Home Blood Collection and Micro Sampling
Devices Market for Push-Button Method of Sample Collection, 2021-2030
11.3.3. At-Home Blood
Collection and Micro Sampling Devices Market, 2021-2030: Analysis by Area of Application
11.3.3.1. At-Home Blood Collection and Micro Sampling
Device Market for Diagnostics, 2021-2030
11.3.3.2. At-Home Blood Collection and Micro Sampling
Device Market for Research, 2021-2030
11.3.3.3. At-Home Blood Collection and Micro Sampling
Device Market for Other Areas of Application, 2021-2030
11.3.4. At-Home Blood Collection and Micro Sampling Devices
Market, 2021-2030: Analysis by Region
11.3.4.1. At-Home Blood Collection and Micro Sampling
Devices Market in North America, 2021- 2030
11.3.4.2. At-Home Blood Collection and Micro Sampling
Devices Market in Europe, 2021- 2030
11.3.4.3. At-Home Blood Collection and Micro Sampling
Devices Market in Asia-Pacific, 2021-2030
14. CONCLUSION
15. EXECUTIVE
INSIGHT(S)
16. APPENDIX 1:
TABULATED DATA
17. APPENDIX 2:
LIST OF COMPANIES AND ORGANIZATIONS
Contact Details
Ben Johnson
+1 (415)
800 3415
+44
(122) 391 1091
Comments
Post a Comment